Six month immunogenicity of COVID-19 mRNA-BNT162b2 vaccine in actively treated cancer patients: updated results of the Vax-On study
Title:
Six month immunogenicity of COVID-19 mRNA-BNT162b2 vaccine in actively treated cancer patients: updated results of the Vax-On study
Author:
Nelli, F. Fabbri, A. Onorato, A. Giannarelli, D. Silvestri, M.A. Pessina, G. Giron Berrios, J.R. Virtuoso, A. Marrucci, E. Schirripa, M. Mazzotta, M. Panichi, V. Cercola, P. Signorelli, C. Chilelli, M.G. Primi, F. Ruggeri, E.M.